方正证券：国产骨科机器人持续跨越式成长 闭环生态是未来发展关键

Industry Insights - The continuous improvement in payment systems is expected to enhance the penetration of orthopedic robots, driven by the inclusion of orthopedic robot-related costs in medical insurance directories across 23 provinces in China, with pricing ranging from 8,000 to 40,000 yuan [1] - The aging population is leading to a sustained increase in demand for orthopedic surgeries, yet the penetration rate of orthopedic robots in China remains below 1%, significantly lower than in the U.S. market, primarily due to tight hospital budgets and complex procurement processes [1] Company Developments - Domestic orthopedic robots have reached performance levels comparable to imported models, with companies like Tianzhihang achieving international leading standards in precision for complex surgeries, particularly in the spine and pelvis [2] - The development of a closed-loop ecosystem involving "equipment + consumables + services" is crucial for profitability and international expansion for domestic companies, as it allows for diversified revenue streams and enhanced customer loyalty [2] Technological Advancements - Companies are focusing on the intelligent and diversified upgrade of robotic products, with an emphasis on developing a full range of orthopedic products and integrating AI and smart technologies through mergers and acquisitions to strengthen global competitiveness [3]